UY36393A - SYNTHESIS OF PI3K INHIBITOR AND SALTS OF THE SAME - Google Patents

SYNTHESIS OF PI3K INHIBITOR AND SALTS OF THE SAME

Info

Publication number
UY36393A
UY36393A UY0001036393A UY36393A UY36393A UY 36393 A UY36393 A UY 36393A UY 0001036393 A UY0001036393 A UY 0001036393A UY 36393 A UY36393 A UY 36393A UY 36393 A UY36393 A UY 36393A
Authority
UY
Uruguay
Prior art keywords
synthesis
salts
same
pi3k inhibitor
compound
Prior art date
Application number
UY0001036393A
Other languages
Spanish (es)
Inventor
Dr Jan-Georg Peters
Dr Philipp Rubenbauer
Dr Kai Lovis
Stiehl Juergen
Seyfried Martin
Zweifel Theodor
Marty Maurus
Günter Weingärtner
Original Assignee
Bayer Pharma AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Pharma AG filed Critical Bayer Pharma AG
Publication of UY36393A publication Critical patent/UY36393A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Abstract

La presente invención se relaciona con un nuevo método para preparar un compuesto de fórmula (I) o una sal del mismo, con nuevos compuestos intermediarios, con el uso de dichos nuevos compuestos intermediarios en la preparación de dicho compuesto de fórmula (I) o una sal del mismo. La presente invención también se relaciona con formas cristalinas, la forma A, de un compuesto de fórmula (I), composiciones farmacéuticas y usos de las mismas.The present invention relates to a new method for preparing a compound of formula (I) or a salt thereof, with new intermediates, with the use of said new intermediates in the preparation of said compound of formula (I) or a Get out of it. The present invention also relates to crystalline forms, form A, of a compound of formula (I), pharmaceutical compositions and uses thereof.

UY0001036393A 2014-11-07 2015-11-05 SYNTHESIS OF PI3K INHIBITOR AND SALTS OF THE SAME UY36393A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP14192207 2014-11-07

Publications (1)

Publication Number Publication Date
UY36393A true UY36393A (en) 2016-06-30

Family

ID=51866062

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001036393A UY36393A (en) 2014-11-07 2015-11-05 SYNTHESIS OF PI3K INHIBITOR AND SALTS OF THE SAME

Country Status (4)

Country Link
AR (1) AR102569A1 (en)
TW (1) TW201625632A (en)
UY (1) UY36393A (en)
WO (1) WO2016071382A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018215282A1 (en) 2017-05-26 2018-11-29 Bayer Pharma Aktiengesellschaft Combination of bub1 and pi3k inhibitors
CN112824387B (en) * 2019-11-21 2023-03-21 济南尚博生物科技有限公司 2-methyl nicotinate and preparation method and application thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA113280C2 (en) * 2010-11-11 2017-01-10 AMINOSPIRT-SUBSTITUTED Derivatives of 2,3-Dihydroimimidase $ 1,2-c] QINAZOLINE, SUITABLE FOR THE TREATMENT OF HYPERPROLIFERATIVE DISORDERS, DISEASES AND DISEASES

Also Published As

Publication number Publication date
TW201625632A (en) 2016-07-16
WO2016071382A1 (en) 2016-05-12
AR102569A1 (en) 2017-03-08

Similar Documents

Publication Publication Date Title
ECSP18092481A (en) PYRIMIDIN-2-ILAMINO-1H-PYRAZOLES AS LRRK2 INHIBITORS FOR USE IN THE TREATMENT OF NEURODEGENERATIVE DISORDERS
CY1122222T1 (en) COMPOSITION OF BORON SALTS AND THEIR USES
CO2017001884A2 (en) Polymorphs of selinexor
BR112017013491A2 (en) fused pyrimidine compounds for the treatment of hiv
CU20160149A7 (en) FUSIONED BICYCLIC HETEROARILO OR ARILO COMPOUNDS AND ITS USE AS IRAK4 INHIBITORS
CR20150472A (en) USE OF PIRAZOLOPIRIMIDINE DERIVATIVES FOR THE TREATMENT OF PI3Kd-RELATED DISORDERS
DOP2017000178A (en) BACE1 SELECTIVE INHIBITORS
PE20160862A1 (en) SYK INHIBITORS POLYMORPH
BR112017013440A2 (en) isoquinoline compounds for the treatment of hiv
NI201700054A (en) SYNTHESIS OF COPANLISIB AND ITS SALT DICHLORHYDRATE
CL2017000715A1 (en) 1-alkyl-6-oxo-1,6-dihydropyridin-3-yl compounds
CL2018002089A1 (en) Tlr7 agonist maleate, its crystalline forms c, d and e, its preparation processes and its use
CL2017001130A1 (en) Synthesis of copanlisib and its dihydrochloride salt
CL2015002488A1 (en) Novel abexinostat salt, related crystalline form, method of preparation of this and the pharmaceutical compositions containing it
UY36145A (en) Compounds of 1, 3, 4-thiadiazole and use thereof for the treatment of cancer
CR20160016A (en) SUBSTITUTED PIRAZOLPIRIDINS
UY36110A (en) QUINASE INHIBITORS RELATED TO TROPOMIOSINE
DOP2018000049A (en) COMPOUNDS FOR USE IN ANTIBACTERIAL APPLICATIONS
CL2019000487A1 (en) Triazolopyrazinone derivative useful as a human pde1 inhibitor.
NI201500176A (en) PRODROG DERIVATIVES OF SUBSTITUTED TRIAZOLPYRIDINES
BR112016017087A8 (en) alpha crystalline form of the monobenzoate compound a and its method of preparation and pharmaceutical composition comprising it
UY36393A (en) SYNTHESIS OF PI3K INHIBITOR AND SALTS OF THE SAME
DOP2016000325A (en) COMPOUNDS, PHARMACEUTICAL COMPOSITION AND ITS USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20220705